A compound represented by formula (1) (in the formula: ring-D represents a three- to eight-membered hydrocarbon ring; R
a
represents an optionally substituted amino C
1-6
alkyl group or the like; R
b1
and R
b2
each independently represent a hydrogen atom, a halogen atom, or the like; R
c
represents an optionally substituted C
6-10
aryl group or the like; R
d
represents a hydrogen atom or the like; and ring-Q represents a (hetero)aryl group or the like which may be substituted with a carboxyl group or the like) or a pharmaceutically acceptable salt thereof exhibits an excellent FXIa inhibitory activity, and is useful as a therapeutic agent against thrombosis or the like.